GlobeNewswire 01/12/2025 Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
GlobeNewswire 28/11/2025 Halper Sadeh LLC Encourages AXTA, SEMR, CDTX Shareholders to Contact the Firm to Discuss Their Right...
GlobeNewswire 28/11/2025 HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, ...
TeleTrader 25/11/2025 US closes higher, Dow jumps over 600 pts
GlobeNewswire 25/11/2025 Amphista Therapeutics announces new AMX-883 data to be presented at the ASH Annual Meeting and Expos...
GlobeNewswire 25/11/2025 Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechani...
TeleTrader 24/11/2025 US closes higher with rate cut hopes in focus
TeleTrader 24/11/2025 US opens higher as holiday week begins
GlobeNewswire 24/11/2025 Biotech Valuations Rise as New Clinical Platforms Show Progress
GlobeNewswire 24/11/2025 Neuphoria Therapeutics Inc. Sends Letter to Stockholders
GlobeNewswire 22/11/2025 Halper Sadeh LLC Encourages THS, CDTX, SPNS Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire 20/11/2025 Zapata Quantum Adds Financial Veteran William Klitgaard to Board as Company Aims to Relist on Nation...
TeleTrader 20/11/2025 Valo Health partners with Merck in $3 billion deal
GlobeNewswire 19/11/2025 Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025
GlobeNewswire 19/11/2025 SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
GlobeNewswire 17/11/2025 Adcytherix Powers Ahead: Technology and Team in Place to Deliver Strategy and Build an ADC Powerhous...
GlobeNewswire 14/11/2025 $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cidara Therapeutics, Inc....
GlobeNewswire 14/11/2025 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cidara Ther...
GlobeNewswire 14/11/2025 IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
TeleTrader 14/11/2025 Merck to buy Cidara for about $9.2B
GlobeNewswire 14/11/2025 Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results
GlobeNewswire 13/11/2025 Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted ...
GlobeNewswire 13/11/2025 PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
TeleTrader 11/11/2025 Dow up 550 pts at close, govt shutdown end in sight
GlobeNewswire 11/11/2025 Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value